Jeil Pharma Holdings Inc

KSE 002620.KS

Jeil Pharma Holdings Inc Return on Capital Employed (ROCE) for the year ending December 31, 2023: 4.48%

Jeil Pharma Holdings Inc Return on Capital Employed (ROCE) is 4.48% for the year ending December 31, 2023, a 127.15% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Jeil Pharma Holdings Inc Return on Capital Employed (ROCE) for the year ending December 31, 2022 was -16.49%, a -3,142.36% change year over year.
  • Jeil Pharma Holdings Inc Return on Capital Employed (ROCE) for the year ending December 31, 2021 was -0.51%, a -107.98% change year over year.
  • Jeil Pharma Holdings Inc Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 6.37%, a 139.62% change year over year.
  • Jeil Pharma Holdings Inc Return on Capital Employed (ROCE) for the year ending December 31, 2019 was -16.09%, a -1,039.15% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
KSE: 002620.KS

Jeil Pharma Holdings Inc

CEO Mr. Seung-Soo Han
IPO Date Jan. 4, 2000
Location South Korea
Headquarters 343, Sapyeong-daero
Employees 39
Sector Health Care
Industries
Description

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.

Similar companies

000640.KS

Dong-A Socio Holdings Co., Ltd.

USD 68.20

0.14%

002390.KS

HANDOK Inc.

USD 8.46

0.09%

003000.KS

Bukwang Pharmaceutical Co., Ltd.

USD 3.32

0.12%

000020.KS

Dongwha Pharm.Co.,Ltd

USD 4.37

0.43%

003120.KS

Ilsung Pharmaceuticals Co., Ltd.

USD 10.98

-0.31%

StockViz Staff

January 15, 2025

Any question? Send us an email